The global Viral and Non-Viral Vector Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Viral and Non-Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-Viral Vector Manufacturing. This report contains market size and forecasts of Viral and Non-Viral Vector Manufacturing in global, including the following market information:
- Global Viral and Non-Viral Vector Manufacturing Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Viral Vectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral and Non-Viral Vector Manufacturing include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc and Sartorius AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Viral and Non-Viral Vector Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral and Non-Viral Vector Manufacturing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Type, 2022 (%)
- Viral Vectors
- Non-Viral Vectors
Global Viral and Non-Viral Vector Manufacturing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Application, 2022 (%)
- Gene Therapy
- Vaccinology
- Cell Therapy
- Others
Global Viral and Non-Viral Vector Manufacturing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Viral and Non-Viral Vector Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Viral and Non-Viral Vector Manufacturing revenues share in global market, 2022 (%)
key players include:
- Boehringer Ingelheim
- Catalent, Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- Genscript Biotech Corporation
- Lonza Group AG
- Merck KGaA Inc.
- Oxford Biomedica Plc
- Sartorius AG
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Wuxi AppTec
- Acuitas Therapeutics
- Evonik Industries AG
- Exelead, Inc.
- Entos Pharmaceuticals
- Genevant Sciences GmbH
- T&T Scientific Corporation
- Moderna, Inc.
- CureVac N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral and Non-Viral Vector Manufacturing, market overview.
Chapter 2: Global Viral and Non-Viral Vector Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Viral and Non-Viral Vector Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral and Non-Viral Vector Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Viral and Non-Viral Vector Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral and Non-Viral Vector Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral and Non-Viral Vector Manufacturing Overall Market Size
2.1 Global Viral and Non-Viral Vector Manufacturing Market Size: 2022 VS 2032
2.2 Global Viral and Non-Viral Vector Manufacturing Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral and Non-Viral Vector Manufacturing Players in Global Market
3.2 Top Global Viral and Non-Viral Vector Manufacturing Companies Ranked by Revenue
3.3 Global Viral and Non-Viral Vector Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Viral and Non-Viral Vector Manufacturing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Viral and Non-Viral Vector Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral and Non-Viral Vector Manufacturing Market Size Markets, 2022 & 2032
4.1.2 Viral Vectors
4.1.3 Non-Viral Vectors
4.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2018-2023
4.2.2 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, 2024-2032
4.2.3 By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral and Non-Viral Vector Manufacturing Market Size, 2022 & 2032
5.1.2 Gene Therapy
5.1.3 Vaccinology
5.1.4 Cell Therapy
5.1.5 Others
5.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2018-2023
5.2.2 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, 2024-2032
5.2.3 By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Viral and Non-Viral Vector Manufacturing Market Size, 2022 & 2032
6.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2018-2023
6.2.2 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue, 2024-2032
6.2.3 By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032
6.3.2 US Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.3.3 Canada Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.3.4 Mexico Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032
6.4.2 Germany Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.3 France Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.4 U.K. Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.5 Italy Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.6 Russia Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.7 Nordic Countries Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.4.8 Benelux Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032
6.5.2 China Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.5.3 Japan Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.5.4 South Korea Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.5.5 Southeast Asia Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.5.6 India Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032
6.6.2 Brazil Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.6.3 Argentina Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032
6.7.2 Turkey Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.7.3 Israel Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.7.4 Saudi Arabia Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
6.7.5 UAE Viral and Non-Viral Vector Manufacturing Market Size, 2018-2032
7 Viral and Non-Viral Vector Manufacturing Companies Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Company Summary
7.1.2 Boehringer Ingelheim Business Overview
7.1.3 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.1.4 Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.1.5 Boehringer Ingelheim Key News & Latest Developments
7.2 Catalent, Inc.
7.2.1 Catalent, Inc. Company Summary
7.2.2 Catalent, Inc. Business Overview
7.2.3 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.2.4 Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.2.5 Catalent, Inc. Key News & Latest Developments
7.3 FUJIFILM Holdings Corporation
7.3.1 FUJIFILM Holdings Corporation Company Summary
7.3.2 FUJIFILM Holdings Corporation Business Overview
7.3.3 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.3.4 FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.3.5 FUJIFILM Holdings Corporation Key News & Latest Developments
7.4 Danaher Corporation
7.4.1 Danaher Corporation Company Summary
7.4.2 Danaher Corporation Business Overview
7.4.3 Danaher Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.4.4 Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.4.5 Danaher Corporation Key News & Latest Developments
7.5 Genscript Biotech Corporation
7.5.1 Genscript Biotech Corporation Company Summary
7.5.2 Genscript Biotech Corporation Business Overview
7.5.3 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.5.4 Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.5.5 Genscript Biotech Corporation Key News & Latest Developments
7.6 Lonza Group AG
7.6.1 Lonza Group AG Company Summary
7.6.2 Lonza Group AG Business Overview
7.6.3 Lonza Group AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.6.4 Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.6.5 Lonza Group AG Key News & Latest Developments
7.7 Merck KGaA Inc.
7.7.1 Merck KGaA Inc. Company Summary
7.7.2 Merck KGaA Inc. Business Overview
7.7.3 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.7.4 Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.7.5 Merck KGaA Inc. Key News & Latest Developments
7.8 Oxford Biomedica Plc
7.8.1 Oxford Biomedica Plc Company Summary
7.8.2 Oxford Biomedica Plc Business Overview
7.8.3 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.8.4 Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.8.5 Oxford Biomedica Plc Key News & Latest Developments
7.9 Sartorius AG
7.9.1 Sartorius AG Company Summary
7.9.2 Sartorius AG Business Overview
7.9.3 Sartorius AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.9.4 Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.9.5 Sartorius AG Key News & Latest Developments
7.10 Takara Bio Inc.
7.10.1 Takara Bio Inc. Company Summary
7.10.2 Takara Bio Inc. Business Overview
7.10.3 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.10.4 Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.10.5 Takara Bio Inc. Key News & Latest Developments
7.11 Thermo Fisher Scientific Inc.
7.11.1 Thermo Fisher Scientific Inc. Company Summary
7.11.2 Thermo Fisher Scientific Inc. Business Overview
7.11.3 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.11.4 Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.11.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.12 Wuxi AppTec
7.12.1 Wuxi AppTec Company Summary
7.12.2 Wuxi AppTec Business Overview
7.12.3 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.12.4 Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.12.5 Wuxi AppTec Key News & Latest Developments
7.13 Acuitas Therapeutics
7.13.1 Acuitas Therapeutics Company Summary
7.13.2 Acuitas Therapeutics Business Overview
7.13.3 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.13.4 Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.13.5 Acuitas Therapeutics Key News & Latest Developments
7.14 Evonik Industries AG
7.14.1 Evonik Industries AG Company Summary
7.14.2 Evonik Industries AG Business Overview
7.14.3 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.14.4 Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.14.5 Evonik Industries AG Key News & Latest Developments
7.15 Exelead, Inc.
7.15.1 Exelead, Inc. Company Summary
7.15.2 Exelead, Inc. Business Overview
7.15.3 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.15.4 Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.15.5 Exelead, Inc. Key News & Latest Developments
7.16 Entos Pharmaceuticals
7.16.1 Entos Pharmaceuticals Company Summary
7.16.2 Entos Pharmaceuticals Business Overview
7.16.3 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.16.4 Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.16.5 Entos Pharmaceuticals Key News & Latest Developments
7.17 Genevant Sciences GmbH
7.17.1 Genevant Sciences GmbH Company Summary
7.17.2 Genevant Sciences GmbH Business Overview
7.17.3 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.17.4 Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.17.5 Genevant Sciences GmbH Key News & Latest Developments
7.18 T&T Scientific Corporation
7.18.1 T&T Scientific Corporation Company Summary
7.18.2 T&T Scientific Corporation Business Overview
7.18.3 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.18.4 T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.18.5 T&T Scientific Corporation Key News & Latest Developments
7.19 Moderna, Inc.
7.19.1 Moderna, Inc. Company Summary
7.19.2 Moderna, Inc. Business Overview
7.19.3 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.19.4 Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.19.5 Moderna, Inc. Key News & Latest Developments
7.20 CureVac N.V.
7.20.1 CureVac N.V. Company Summary
7.20.2 CureVac N.V. Business Overview
7.20.3 CureVac N.V. Viral and Non-Viral Vector Manufacturing Major Product Offerings
7.20.4 CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue in Global Market (2018-2023)
7.20.5 CureVac N.V. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Viral and Non-Viral Vector Manufacturing Market Opportunities & Trends in Global Market
Table 2. Viral and Non-Viral Vector Manufacturing Market Drivers in Global Market
Table 3. Viral and Non-Viral Vector Manufacturing Market Restraints in Global Market
Table 4. Key Players of Viral and Non-Viral Vector Manufacturing in Global Market
Table 5. Top Viral and Non-Viral Vector Manufacturing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Viral and Non-Viral Vector Manufacturing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Viral and Non-Viral Vector Manufacturing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Viral and Non-Viral Vector Manufacturing Product Type
Table 9. List of Global Tier 1 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral and Non-Viral Vector Manufacturing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Viral and Non-Viral Vector Manufacturing Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2024-2032
Table 30. Boehringer Ingelheim Company Summary
Table 31. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Product Offerings
Table 32. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 33. Boehringer Ingelheim Key News & Latest Developments
Table 34. Catalent, Inc. Company Summary
Table 35. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 36. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 37. Catalent, Inc. Key News & Latest Developments
Table 38. FUJIFILM Holdings Corporation Company Summary
Table 39. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 40. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 41. FUJIFILM Holdings Corporation Key News & Latest Developments
Table 42. Danaher Corporation Company Summary
Table 43. Danaher Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 44. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 45. Danaher Corporation Key News & Latest Developments
Table 46. Genscript Biotech Corporation Company Summary
Table 47. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 48. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 49. Genscript Biotech Corporation Key News & Latest Developments
Table 50. Lonza Group AG Company Summary
Table 51. Lonza Group AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 52. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 53. Lonza Group AG Key News & Latest Developments
Table 54. Merck KGaA Inc. Company Summary
Table 55. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 56. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 57. Merck KGaA Inc. Key News & Latest Developments
Table 58. Oxford Biomedica Plc Company Summary
Table 59. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Product Offerings
Table 60. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 61. Oxford Biomedica Plc Key News & Latest Developments
Table 62. Sartorius AG Company Summary
Table 63. Sartorius AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 64. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 65. Sartorius AG Key News & Latest Developments
Table 66. Takara Bio Inc. Company Summary
Table 67. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 68. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 69. Takara Bio Inc. Key News & Latest Developments
Table 70. Thermo Fisher Scientific Inc. Company Summary
Table 71. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 72. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 73. Thermo Fisher Scientific Inc. Key News & Latest Developments
Table 74. Wuxi AppTec Company Summary
Table 75. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Product Offerings
Table 76. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 77. Wuxi AppTec Key News & Latest Developments
Table 78. Acuitas Therapeutics Company Summary
Table 79. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Product Offerings
Table 80. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 81. Acuitas Therapeutics Key News & Latest Developments
Table 82. Evonik Industries AG Company Summary
Table 83. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Product Offerings
Table 84. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 85. Evonik Industries AG Key News & Latest Developments
Table 86. Exelead, Inc. Company Summary
Table 87. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 88. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 89. Exelead, Inc. Key News & Latest Developments
Table 90. Entos Pharmaceuticals Company Summary
Table 91. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Product Offerings
Table 92. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 93. Entos Pharmaceuticals Key News & Latest Developments
Table 94. Genevant Sciences GmbH Company Summary
Table 95. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Product Offerings
Table 96. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 97. Genevant Sciences GmbH Key News & Latest Developments
Table 98. T&T Scientific Corporation Company Summary
Table 99. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Product Offerings
Table 100. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 101. T&T Scientific Corporation Key News & Latest Developments
Table 102. Moderna, Inc. Company Summary
Table 103. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 104. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 105. Moderna, Inc. Key News & Latest Developments
Table 106. CureVac N.V. Company Summary
Table 107. CureVac N.V. Viral and Non-Viral Vector Manufacturing Product Offerings
Table 108. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue (US$, Mn) & (2018-2023)
Table 109. CureVac N.V. Key News & Latest Developments
List of Figures
Figure 1. Viral and Non-Viral Vector Manufacturing Segment by Type in 2022
Figure 2. Viral and Non-Viral Vector Manufacturing Segment by Application in 2022
Figure 3. Global Viral and Non-Viral Vector Manufacturing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Viral and Non-Viral Vector Manufacturing Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Viral and Non-Viral Vector Manufacturing Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral and Non-Viral Vector Manufacturing Revenue in 2022
Figure 8. By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 9. By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 10. By Type - Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 12. By Application - Global Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 14. By Region - Global Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 15. By Country - North America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 16. US Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 20. Germany Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 21. France Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 28. China Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 32. India Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 34. Brazil Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Viral and Non-Viral Vector Manufacturing Revenue Market Share, 2018-2032
Figure 37. Turkey Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Viral and Non-Viral Vector Manufacturing Revenue, (US$, Mn), 2018-2032
Figure 41. Boehringer Ingelheim Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Catalent, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. FUJIFILM Holdings Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Danaher Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Genscript Biotech Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Lonza Group AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck KGaA Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Oxford Biomedica Plc Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sartorius AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Takara Bio Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Thermo Fisher Scientific Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Wuxi AppTec Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Acuitas Therapeutics Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Evonik Industries AG Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Exelead, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Entos Pharmaceuticals Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Genevant Sciences GmbH Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. T&T Scientific Corporation Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Moderna, Inc. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. CureVac N.V. Viral and Non-Viral Vector Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
